The wireless type segment by type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Surgical Smart Glasses Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, End User and Country.” The Europe surgical smart glasses market is expected to reach US$ 93,915.65 thousand by 2028 from US$ 49,512.24 thousand in 2021; it is estimated to grow at a CAGR of 9.6% from 2021 to 2028. The report highlights trends prevailing in the Europe surgical smart glasses market and the factors driving market along with those that act as hindrances. 

There is a rise in investments for medical research and development activities across the world. Healthcare sectors, as well as government authorities, from different countries are actively supporting the deployment of smart devices to improve procedural outcomes. In addition, increasing Food and Drug Administration (FDA) and Continuing Education (CE)approvals are also anticipated to have a constructive impact on the growth of the surgical smart glasses market during the forecast period. In March 2021, Vuzix Corporation received purchase order for its Vuzix M400 smart glasses, worth of US$ 0.25 million from a healthcare and surgical training solutions provider. According to the company, a substantial number of healthcare professionals in developed regions prefer using smart glasses during surgical procedures. The increasing number of product approvals and introductions is also encouraging healthcare professionals to opt for smart glasses. In July 2020, healthcare professionals at the Manresa University Health Care Network, Spain, procured smart glasses for using them during gastrointestinal surgeries. Such developments are creating favorable environment for the growth of the surgical smart glasses market. Also, the rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases (CVDs), stroke, and kidney diseases, is resulting in the rise in number of surgical procedures being performed worldwide, eventually boosting the growth of the surgical smart glasses market.

Continuation in the impact of the COVID-19 pandemic on society and healthcare in Europe is compelling healthcare workers to operate with greater precautions, alongside ensuring improved productivity. Cardiologists and other surgeons can use smart glasses for surgical assistance to perform critical procedures with the help of a remote expert. Medtronic, a global healthcare solutions company, announced its plan of setting up a unit for cardiac and vascular surgery assistance smart glasses in a selected number of hospitals in the Benelux region. Therefore, the growing awareness regarding telecommunications systems is likely to boost the demand for surgical smart glasses during the COVID-19 pandemic in Europe, in the coming years.

Based on type, the Europe surgical smart glasses market is segmented into wire type and wireless type. Based on end user, the Europe surgical smart glasses market is segmented into hospital, clinics, and others. Geographically, the Europe surgical smart glasses market can be sub-segmented into Germany, Italy, France, Spain, U.K and Rest of Europe.

Taiwan Main Orthopaedic Biotechnology, IRISTICK, Vuzix Corporation, AMA XpertEye, ImmersiveTouch, Inc., and Microsoft HoloLens (Microsoft Corporation) are among the leading companies operating in the Europe surgical smart glasses market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com